Read the latest positive news, breakthroughs, and inspiring stories about congo health, curated daily by BrightWire.
More than 250 people exposed to Ebola in Congo are testing an experimental pill that could prevent them from developing the disease. The trial offers new hope as the outbreak has already claimed 4,000 lives.
Health workers in the Democratic Republic of Congo are receiving the first doses of a promising Ebola vaccine as part of groundbreaking clinical trials. European disease experts are also heading to the region to help contain the outbreak and protect communities.
Health workers are fighting to protect children in the Democratic Republic of Congo as a promising vaccine shows early signs it could help stop a deadly Ebola outbreak. After losing more than 300 young lives, a breakthrough in animal studies is opening the door to new protection.
Scientists are racing to test two promising treatments for a rare form of Ebola that has already helped 210 people recover in the Democratic Republic of Congo. The groundbreaking trial could deliver lifesaving answers within months.
Scientists have enrolled the first patient in a groundbreaking trial to find effective treatments for the deadly Bundibugyo strain of Ebola in the Democratic Republic of Congo. The trial brings hope to a region where more than 1,400 people have been infected since May, with currently no approved treatments available.
Scientists are fast-tracking three promising vaccines to fight the Ebola outbreak in Congo and Uganda, with clinical trials starting within months. New funding of $62 million is speeding up development of the first vaccines specifically designed for the Bundibugyo virus strain.
In a breakthrough moment for the outbreak response, five patients have recovered from the Bundibugyo Ebola strain, which has no approved treatment or vaccine. Health officials say the recoveries prove that with early care and community support, beating this virus is possible.
